[中化控股股份有限公司] Q1 2026 EPS 1.57 NTD
Key facts
- [中化控股股份有限公司] Q1 2026 EPS 1.57 NTD
- 中化控股股份有限公司 reported a Q1 2026 EPS of 1.57 NTD, with operating revenue at 2.229 billion NTD.
- Source: PR Times
- Date: March 1, 2026
Direct answer
中化控股股份有限公司 reported a Q1 2026 EPS of 1.57 NTD, with operating revenue at 2.229 billion NTD.
- Citation
- [中化控股股份有限公司] Q1 2026 EPS 1.57 NTD (March 1, 2026), PR Times
- Source
- PR Times
- Date
- March 1, 2026
中化控股股份有限公司 reported a Q1 2026 EPS of 1.57 NTD, with operating revenue at 2.229 billion NTD.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: May 16, 2026 at 08:00 (1823h 0m after Published)
- 🤖 AI Analyzed: May 16, 2026 at 09:42 (1h 42m after Collected)
Company Code: 3716
Company Name: 中化控股股份有限公司
Industry: Biotech and Medical
Year/Quarter: 2026 Q1
Basic EPS: 1.57 NTD
Operating Revenue: 2.229 billion NTD
Net Income after Tax: 193 million NTD
Company Name: 中化控股股份有限公司
Industry: Biotech and Medical
Year/Quarter: 2026 Q1
Basic EPS: 1.57 NTD
Operating Revenue: 2.229 billion NTD
Net Income after Tax: 193 million NTD
FAQ
What are the key facts in this article?
中化控股股份有限公司 reported a Q1 2026 EPS of 1.57 NTD, with operating revenue at 2.229 billion NTD.
What is the direct answer?
中化控股股份有限公司 reported a Q1 2026 EPS of 1.57 NTD, with operating revenue at 2.229 billion NTD.
What is the source and date?
PR Times: https://openapi.twse.com.tw/financial/twse-fin-3716-2026Q1 | March 1, 2026